{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:01:39Z","timestamp":1780041699788,"version":"3.53.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.critrevonc.2026.105338","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T07:25:47Z","timestamp":1776237947000},"page":"105338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The dichotomous function of eicosanoid signaling in the pathogenesis and therapeutic management of lung cancer"],"prefix":"10.1016","volume":"223","author":[{"given":"Woo Hyun","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105338_bib1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.prostaglandins.2017.12.002","article-title":"Iloprost, a prostacyclin analog, inhibits the invasion of ovarian cancer cells by downregulating matrix metallopeptidase-2 (MMP-2) through the IP-dependent pathway","volume":"134","author":"Ahn","year":"2018","journal-title":"Prostaglandins & Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105338_bib2","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1186\/s13046-019-1478-3","article-title":"Inhibition of lung cancer growth and metastasis by DHA and its metabolite, RvD1, through miR-138-5p\/FOXC1 pathway","volume":"38","author":"Bai","year":"2019","journal-title":"J. Exp. & Clin. Cancer Res."},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105338_bib3","doi-asserted-by":"crossref","first-page":"31270","DOI":"10.18632\/oncotarget.16116","article-title":"PGE2\/EP3\/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells","volume":"8","author":"Bazzani","year":"2017","journal-title":"Oncotarget"},{"issue":"42","key":"10.1016\/j.critrevonc.2026.105338_bib4","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1038\/onc.2015.2","article-title":"Wnt7a is a novel inducer of \u03b2-catenin-independent tumor-suppressive cellular senescence in lung cancer","volume":"34","author":"Bikkavilli","year":"2015","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.critrevonc.2026.105338_bib5","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1158\/0008-5472.CAN-23-2627","article-title":"CRISPR-Cas9 screening identifies KRAS-induced COX2 as a driver of immunotherapy resistance in lung cancer","volume":"84","author":"Boumelha","year":"2024","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105338_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s13402-020-00558-w","article-title":"Enhanced migration of breast and lung cancer cells deficient for cN-II and CD73 via COX-2\/PGE2\/AKT axis regulation","volume":"44","author":"Cadassou","year":"2021","journal-title":"Cell. Oncol. (Dordr. )"},{"key":"10.1016\/j.critrevonc.2026.105338_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.molimm.2017.06.018","article-title":"Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2\/PGE(2)\/\u03b2-catenin signalling pathway","volume":"90","author":"Che","year":"2017","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105338_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1134\/S000629792305005X","article-title":"Blood oxylipin profiles as markers of oncological diseases","volume":"88","author":"Chistyakov","year":"2023","journal-title":"Biochemistry (Moscow)"},{"key":"10.1016\/j.critrevonc.2026.105338_bib9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.18632\/oncotarget.28190","article-title":"PACER lncRNA regulates COX-2 expression in lung cancer cells","volume":"13","author":"Desind","year":"2022","journal-title":"Oncotarget"},{"issue":"19","key":"10.1016\/j.critrevonc.2026.105338_bib10","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1200\/JCO.2016.71.3743","article-title":"Phase III randomized, placebo-controlled, double-blind trial of celecoxib in addition to standard chemotherapy for advanced non-small-cell lung cancer with cyclooxygenase-2 overexpression: CALGB 30801 (alliance)","volume":"35","author":"Edelman","year":"2017","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105338_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2024.119810","article-title":"ERK5 mediates pro-tumorigenic phenotype in non-small lung cancer cells induced by PGE2","volume":"1871","author":"Filippelli","year":"2024","journal-title":"Biochim. Et. Biophys. Acta - Mol. Cell Res."},{"key":"10.1016\/j.critrevonc.2026.105338_bib12","first-page":"48","article-title":"Targeting the prostacyclin\/peroxisome proliferator-activated rector gamma axis in lung cancer chemoprevention","volume":"129","author":"Geraci","year":"2018","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105338_bib13","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.1158\/0008-5472.CAN-15-3403","article-title":"Myc expression drives aberrant lipid metabolism in lung cancer","volume":"76","author":"Hall","year":"2016","journal-title":"Cancer Res."},{"issue":"1-2","key":"10.1016\/j.critrevonc.2026.105338_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11010-019-03500-3","article-title":"Inhibition of secretory phospholipase A2 IIa attenuates prostaglandin E2-induced invasiveness in lung adenocarcinoma","volume":"456","author":"Halpern","year":"2019","journal-title":"Mol. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105338_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/cas.15574","article-title":"First-in-human study of ONO-4578, an antagonist of prostaglandin E(2) receptor 4, alone and with nivolumab in solid tumors","volume":"114","author":"Iwasa","year":"2023","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105338_bib16","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1038\/s12276-021-00682-z","article-title":"Leukotriene B4 receptor-2 contributes to KRAS-driven lung tumor formation by promoting interleukin-6-mediated inflammation","volume":"53","author":"Jang","year":"2021","journal-title":"Exp. & Mol. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105338_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115574","article-title":"MHC class II+ macrophage differentiation is impaired in metastasized lungs via PGE2 receptor EP2","volume":"44","author":"Jeong","year":"2025","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105338_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1124\/dmd.123.001463","article-title":"Deciphering the role of fatty acid-metabolizing CYP4F11 in lung cancer and its potential as a drug target","volume":"52","author":"Jia","year":"2024","journal-title":"Drug Metab. Dispos."},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105338_bib19","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/j.ajpath.2022.07.004","article-title":"Resolvin E1 reduces tumor growth in a xenograft model of lung cancer","volume":"192","author":"Kantarci","year":"2022","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105338_bib20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/cas.15671","article-title":"Depletion of tumor-associated macrophages inhibits lung cancer growth and enhances the antitumor effect of cisplatin","volume":"114","author":"Kawaguchi","year":"2023","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105338_bib21","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41419-020-02846-7","article-title":"LXA(4)-FPR2 signaling regulates radiation-induced pulmonary fibrosis via crosstalk with TGF-\u03b2\/Smad signaling","volume":"11","author":"Kim","year":"2020","journal-title":"Cell Death & Dis."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105338_bib22","first-page":"613","article-title":"Cyclooxygenase-2 expression is induced by celecoxib treatment in lung cancer cells and is transferred to neighbor cells via exosomes","volume":"52","author":"Kim","year":"2018","journal-title":"Int. J. Oncol."},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105338_bib23","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/jama.2025.0560","article-title":"Small cell lung cancer: a review","volume":"333","author":"Kim","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.critrevonc.2026.105338_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116265","article-title":"Inflammatory effects of hexavalent chromium in the lung: a comprehensive review","volume":"455","author":"Kouokam","year":"2022","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105338_bib25","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.neo.2021.05.010","article-title":"Naproxen inhibits spontaneous lung adenocarcinoma formation in Kras(G12V) mice","volume":"23","author":"Kumar","year":"2021","journal-title":"Neoplasia"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105338_bib26","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00262-022-03285-3","article-title":"Anti-PD-1 antibody-activated Th17 cells subvert re-invigoration of antitumor cytotoxic T-lymphocytes via myeloid cell-derived COX-2\/PGE(2)","volume":"72","author":"Li","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105338_bib27","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1111\/cas.15760","article-title":"SLC3A2 promotes tumor-associated macrophage polarization through metabolic reprogramming in lung cancer","volume":"114","author":"Li","year":"2023","journal-title":"Cancer Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105338_bib28","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1021\/acs.jafc.0c06890","article-title":"DHA\/EPA-enriched phosphatidylcholine suppresses tumor growth and metastasis via activating peroxisome proliferator-activated receptor \u03b3 in lewis lung cancer mice","volume":"69","author":"Liu","year":"2021","journal-title":"J. Agric. Food Chem."},{"issue":"37","key":"10.1016\/j.critrevonc.2026.105338_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000011971","article-title":"Effect of omega 3 fatty acids on C-reactive protein and interleukin-6 in patients with advanced nonsmall cell lung cancer","volume":"97","author":"Lu","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.critrevonc.2026.105338_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2018.11.033","article-title":"Exosomes and cells from lung cancer pleural exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1","volume":"444","author":"Lukic","year":"2019","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105338_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1158\/1940-6207.CAPR-16-0122","article-title":"Grape seed procyanidin extract mediates antineoplastic effects against lung cancer via modulations of prostacyclin and 15-HETE eicosanoid pathways","volume":"9","author":"Mao","year":"2016","journal-title":"Cancer Prev. Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105338_bib32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41568-025-00791-1","article-title":"Translating premalignant biology to accelerate non-small-cell lung cancer interception","volume":"25","author":"Mazzilli","year":"2025","journal-title":"Nat. Rev. Cancer"},{"issue":"10","key":"10.1016\/j.critrevonc.2026.105338_bib33","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1158\/1940-6207.CAPR-18-0052","article-title":"Prostacyclin and EMT pathway markers for monitoring response to lung cancer chemoprevention","volume":"11","author":"New","year":"2018","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.critrevonc.2026.105338_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2020.106451","article-title":"Role of epoxyeicosatrienoic acids in the lung","volume":"149","author":"Olivares-Rubio","year":"2020","journal-title":"Prostaglandins & Other Lipid Mediat."},{"issue":"36","key":"10.1016\/j.critrevonc.2026.105338_bib35","doi-asserted-by":"crossref","first-page":"38816","DOI":"10.18632\/oncotarget.5558","article-title":"Deletion of cyclooxygenase-2 inhibits K-ras-induced lung carcinogenesis","volume":"6","author":"Pan","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2026.105338_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117662","article-title":"Eicosanoids and Inflammation: a delicate balance of pro-inflammatory and pro-resolving mediators","volume":"245","author":"Park","year":"2026","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105338_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114855","article-title":"Tissue-colonizing disseminated tumor cells secrete prostaglandin E2 to promote NK cell dysfunction and evade anti-metastatic immunity","volume":"43","author":"Pedde","year":"2024","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105338_bib38","doi-asserted-by":"crossref","first-page":"891","DOI":"10.4049\/jimmunol.1501648","article-title":"Deletion of 5-lipoxygenase in the tumor microenvironment promotes lung cancer progression and metastasis through regulating T cell recruitment","volume":"196","author":"Poczobutt","year":"2016","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105338_bib39","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.immuni.2025.05.003","article-title":"A CD4+ T cell-intrinsic complement C5aR2-prostacyclin-IL-1R2 axis orchestrates Th1 cell contraction","volume":"58","author":"Rahman","year":"2025","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.critrevonc.2026.105338_bib40","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1200\/JCO-24-02347","article-title":"De-escalation strategies with immune checkpoint blockers in non-small cell lung cancer: do we already have enough evidence?","volume":"43","author":"Remon","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105338_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1557790","article-title":"Celecoxib prevents malignant progression of smoking-induced lung tumors via suppression of the COX-2\/PGE(2) signaling pathway in mice","volume":"16","author":"Sakurai","year":"2025","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.critrevonc.2026.105338_bib42","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1158\/0008-5472.CAN-17-3977","article-title":"The cytochrome P450 slow metabolizers CYP2C92 and CYP2C93 directly regulate tumorigenesis via reduced epoxyeicosatrienoic acid production","volume":"78","author":"Sausville","year":"2018","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105338_bib43","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41568-025-00803-0","article-title":"Challenges of small cell lung cancer heterogeneity and phenotypic plasticity","volume":"25","author":"Simpson","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105338_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2021.102084","article-title":"Leukotriene inhibition and the risk of lung cancer among U.S. veterans with asthma","volume":"71","author":"Sutton","year":"2021","journal-title":"Pulm. Pharmacol. & Ther."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105338_bib45","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1038\/s41598-024-51967-y","article-title":"Impact of serum eicosapentaenoic acid\/arachidonic acid ratio on overall survival in lung cancer patients treated with pembrolizumab: a pilot study","volume":"14","author":"Tanaka","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105338_bib46","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1940-6207.CAPR-21-0086","article-title":"Intranasal iloprost prevents tumors in a murine lung carcinogenesis model","volume":"15","author":"Tennis","year":"2022","journal-title":"Cancer Prev. Res."},{"key":"10.1016\/j.critrevonc.2026.105338_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.prostaglandins.2019.106344","article-title":"mPGES-1 as a new target to overcome acquired resistance to gefitinib in non-small cell lung cancer cell lines","volume":"143","author":"Terzuoli","year":"2019","journal-title":"Prostaglandins & Other Lipid Mediat."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105338_bib48","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/ijms23010120","article-title":"Cysteinyl leukotriene pathway and cancer","volume":"23","author":"Tsai","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105338_bib49","doi-asserted-by":"crossref","first-page":"89","DOI":"10.33594\/000000506","article-title":"Regulation of epithelial-mesenchymal transition of A549 cells by prostaglandin D(2)","volume":"56","author":"Vafaeinik","year":"2022","journal-title":"Cell. Physiol. Biochem."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105338_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.slasd.2022.11.004","article-title":"Reduced levels of serum EPA and DHA identified in patients with non-small-cell lung cancer using a new rapid validated LC-MS\/MS method","volume":"28","author":"Wang","year":"2023","journal-title":"SLAS Discov."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105338_bib51","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1186\/s12885-019-6379-5","article-title":"PPAR\u03b1 ligand, AVE8134, and cyclooxygenase inhibitor therapy synergistically suppress lung cancer growth and metastasis","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105338_bib52","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.12659\/MSM.915314","article-title":"Expression of cytosolic phospholipase A2 (cPLA2)-arachidonic acid (AA)-cyclooxygenase-2 (COX-2) pathway factors in lung cancer patients and its implication in lung cancer early detection and prognosis","volume":"25","author":"Xin","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.critrevonc.2026.105338_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.prostaglandins.2018.07.003","article-title":"15-Lipoxygenase-2\/15(S)-hydroxyeicosatetraenoic acid regulates cell proliferation and metastasis via the STAT3 pathway in lung adenocarcinoma","volume":"138","author":"Yang","year":"2018","journal-title":"Prostaglandins & Other Lipid Mediat."},{"issue":"8060","key":"10.1016\/j.critrevonc.2026.105338_bib54","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/s41586-025-08626-7","article-title":"Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity","volume":"640","author":"Yang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105338_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118184","article-title":"Eicosanoid metabolites in relation to non-small cell lung cancer","volume":"188","author":"Zelkowska","year":"2025","journal-title":"Biomed. & Pharmacother."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105338_bib56","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/09553002.2021.1846817","article-title":"Celecoxib and Afatinib synergistic enhance radiotherapy sensitivity on human non-small cell lung cancer A549 cells","volume":"97","author":"Zhang","year":"2021","journal-title":"Int. J. Radiat. Biol."},{"issue":"21","key":"10.1016\/j.critrevonc.2026.105338_bib57","doi-asserted-by":"crossref","first-page":"21758","DOI":"10.18632\/aging.103984","article-title":"Caspase-3 knockout attenuates radiation-induced tumor repopulation via impairing the ATM\/p53\/Cox-2\/PGE(2) pathway in non-small cell lung cancer","volume":"12","author":"Zhao","year":"2020","journal-title":"Aging"}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002258?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826002258?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T07:03:27Z","timestamp":1780038207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826002258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":57,"alternative-id":["S1040842826002258"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105338","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The dichotomous function of eicosanoid signaling in the pathogenesis and therapeutic management of lung cancer","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105338"}}